CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 43 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,565 | +559.4% | 27,099 | +284.4% | 0.00% | – |
| Q3 2022 | $6,000 | -79.3% | 7,049 | -75.5% | 0.00% | – |
| Q2 2022 | $29,000 | +93.3% | 28,797 | +217.3% | 0.00% | – |
| Q1 2022 | $15,000 | -78.9% | 9,075 | -69.1% | 0.00% | – |
| Q4 2021 | $71,000 | +273.7% | 29,397 | +315.4% | 0.00% | – |
| Q2 2021 | $19,000 | -38.7% | 7,076 | -28.9% | 0.00% | – |
| Q1 2021 | $31,000 | +63.2% | 9,951 | +84.3% | 0.00% | – |
| Q4 2020 | $19,000 | – | 5,400 | +5300.0% | 0.00% | – |
| Q3 2020 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $2,784,274 | 0.93% |
| CHI Advisors LLC | 2,384,402 | $2,026,742 | 0.54% |
| Telemetry Investments, L.L.C. | 390,000 | $332 | 0.52% |
| Orbimed Advisors | 6,943,654 | $5,902,106 | 0.11% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 548,727 | $466,418 | 0.07% |
| BVF INC/IL | 1,370,947 | $1,165,305 | 0.05% |
| JACKSON SQUARE CAPITAL, LLC | 63,773 | $54,207 | 0.03% |
| Artal Group S.A. | 500,000 | $425 | 0.02% |
| Hikari Power Ltd | 49,959 | $42 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,300 | $135,405 | 0.00% |